Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016.
Journal
American journal of clinical oncology
ISSN: 1537-453X
Titre abrégé: Am J Clin Oncol
Pays: United States
ID NLM: 8207754
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
29
1
2020
medline:
31
7
2020
entrez:
29
1
2020
Statut:
ppublish
Résumé
The objective of this study was to understand recent trends in direct health care expenditures among cancer survivors using novel cost-estimation methods and a nationally representative database. This study was a retrospective analysis of 193,003 adults, ≥18 years of age, using the Medical Expenditure Panel Survey during the years 2009-2016. Manning and Mullahy two-part model was used to calculate adjusted mean and incremental medical expenditures after adjusting for covariates. The mean direct annual health care expenditure among cancer survivors ($13,025.0 [$12,572.0 to $13,478.0]) was nearly 3 times greater than noncancer participants ($4689.3 [$4589.2 to $4789.3]) and were mainly spent on inpatient services, office-based visits, and prescription medications. Cancer survivors had an additional health care expenditure of $4407.6 ($3877.6, $4937.6) per person per year, compared with noncancer participants after adjusting for covariates (P<0.001). The total mean annual direct health care expenditure for cancer survivors increased from $12,960.0 (95% confidence interval: $12,291.0-$13,628.0) in 2009-2010 to $13,807.0 ($12,828.0 to $14,787.0) in 2015-2016. Given the higher health care expenditures among cancer survivors and the increasing prevalence of cancers, cost-saving measures should be planned through multidisciplinary initiatives, collaborative research, and importantly, health care planning and policy changes. Our findings could be helpful in streamlining health care resources and interventions, developing national health care coverage policies, and possibly considering radically new insurance strategies for cancer survivors.
Identifiants
pubmed: 31990757
doi: 10.1097/COC.0000000000000670
pii: 00000421-202005000-00007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
349-355Références
National Cancer Institute (NCI). Cancer statistics. 2018. Available at: www.cancer.gov/about-cancer/understanding/statistics. Accessed July 29, 2019.
Agency for Healthcare Research and Quality (AHRQ). MEPS Topics: Health Care Costs/Expenditures; 2018. Available at: www.meps.ahrq.gov/mepsweb/data_stats/MEPS_topics.jsp?topicid=5Z-1. Accessed June 11, 2019.
Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630–641.
Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev. 1997;18:51–76.
Max W, Rice DP, Sung HY, et al. The economic burden of prostate cancer, California, 1998. Cancer. 2002;94:2906–2913.
Max W, Rice DP, Sung H-Y, et al. The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol. 2003;88:96–103.
Max W, Sung H-Y, Stark B. The economic burden of breast cancer in California. Breast Cancer Res Treat. 2009;116:201–207.
Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87:417–426.
Tangka FK, Trogdon JG, Richardson LC, et al. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010;116:3477–3484.
Given B, Given C, Stommel M. Family and out-of-pocket costs for women with breast cancer. Cancer Pract. 1994;2:187–193.
Langa KM, Fendrick AM, Chernew ME, et al. Out‐of‐pocket health‐care expenditures among older Americans with cancer. Value Health. 2004;7:186–194.
Agency for Healthcare Research and Quality (AHRQ). MEPS: Data Overview; 2018. Available at: meps.ahrq.gov/mepsweb/data_stats/data_overview.jsp. Accessed August 19, 2019.
Agency for Healthcare Research and Quality (AHRQ). MEPS-HC Panel Design and Data Collection Process; 2019. Available at: https://meps.ahrq.gov/survey_comp/hc_data_collection.jsp. Accessed June 9, 2019.
Agency for Healthcare Research and Quality (AHRQ). MEPS HC-036: MEPS 1996-2016 Pooled Linkage Variance Estimation File; 2018. Available at: https://meps.ahrq.gov/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-036. Accessed June 19, 2019.
Agency for Healthcare Research and Quality (AHRQ). MEPS HC-036: 1996-2007 Pooled Estimation File; 2018. Available at: https://meps.ahrq.gov/data_stats/download_data/pufs/h36/h36u07doc.shtml. Accessed July 17, 2019.
Mihaylova B, Briggs A, O’Hagan A, et al. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897–916.
Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–494.
Belotti F, Deb P, Manning WG, et al. twopm: Two-part models. Stata J. 2015;15:3–20.
Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29:2821.
Guy GP Jr, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749.
Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff. 2014;33:1024–1031.
Howard DH, Molinari NA, Thorpe KE. National estimates of medical costs incurred by nonelderly cancer patients. Cancer. 2004;100:883–891.
Mariotto AB, Robin Yabroff K, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–128.
Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117:2791–2800.
Hartman M, Martin AB, Lassman D, et al. National Health Expenditure Accounts Team (NHEA). National health spending in 2013: growth slows, remains in step with the overall economy. Health Aff. 2014;34:150–160.
Hwang TJ, Kesselheim AS, Gyawali B. Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016. JNCI Cancer Spectr. 2018;2:pky016.
Martin AB, Hartman M, Benson J, et al. National Health Expenditure Accounts Team (NHEA). National health spending in 2014: faster growth driven by coverage expansion and prescription drug spending. Health Aff. 2015;35:150–160.
Rubens M, Ramamoorthy V, Saxena A, et al. Palliative care consultation trends among hospitalized patients with advanced cancer in the United States, 2005 to 2014. Am J Hosp Palliat Care. 2019;36:294–301.
Bush TL, Miller SR, Golden AL, et al. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554–1556.